Model
Edge
Pharmaceutical Product Development, LLC
0001003124
Filing Type
10-K
Filing Date
2/24/2011
Updated
2/25/11, 4:50 AM
Filing
10-K
Earnings Release
Exhibits
10-K
FY 2010
EX-10.162
SEVERANCE AGREEMENT
EX-10.277
FIFTH AMENDMENT TO LEASE AGREEMENT
EX-21
SUBSIDIARIES
EX-23.1
CONSENT OF DELOITTE AND TOUCHE LLP.
EX-31.1
CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
EX-31.2
CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
EX-32.1
CERTIFICATION OF CEO PURSUANT TO SECTION 1350
EX-32.2
CERTIFICATION OF CFO PURSUANT TO SECTION 1350
EX-101.INS
XBRL INSTANCE DOCUMENT
GRAPHIC
Graphic
XML
IDEA: XBRL DOCUMENT
EXCEL
IDEA: XBRL DOCUMENT